Abstract

Nucleosomes restrict DNA accessibility throughout eukaryotic genomes, with repercussions for replication, transcription, and other DNA-templated processes. How this globally restrictive organization emerged during evolution remains poorly understood. Here, to better understand the challenges associated with establishing globally restrictive chromatin, we express histones in a naïve system that has not evolved to deal with nucleosomal structures: Escherichia coli. We find that histone proteins from the archaeon Methanothermus fervidus assemble on the E. coli chromosome in vivo and protect DNA from micrococcal nuclease digestion, allowing us to map binding footprints genome-wide. We show that higher nucleosome occupancy at promoters is associated with lower transcript levels, consistent with local repressive effects. Surprisingly, however, this sudden enforced chromatinization has only mild repercussions for growth unless cells experience topological stress. Our results suggest that histones can become established as ubiquitous chromatin proteins without interfering critically with key DNA-templated processes.

Data availability

Sequencing data have been deposited in GEO under accession code GSE127680.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Maria Rojec

    Institute of Clinical Sciences, London Institute of Medical Sciences (LMS), London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Antoine Hocher

    Institute of Clinical Sciences, London Institute of Medical Sciences (LMS), London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Kathryn M Stevens

    Institute of Clinical Sciences, London Institute of Medical Sciences (LMS), London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Matthias Merkenschlager

    Institute of Clinical Sciences, London Institute of Medical Sciences (LMS), London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2889-3288
  5. Tobias Warnecke

    Institute of Clinical Sciences, London Institute of Medical Sciences (LMS), London, United Kingdom
    For correspondence
    tobias.warnecke@imperial.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4936-5428

Funding

Medical Research Council (MC_A658_5TY40)

  • Tobias Warnecke

Engineering and Physical Sciences Research Council (EP/R029407/1)

  • Tobias Warnecke

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. David M Truong, NYU Langone Health, United States

Version history

  1. Received: June 4, 2019
  2. Accepted: November 5, 2019
  3. Accepted Manuscript published: November 6, 2019 (version 1)
  4. Version of Record published: November 20, 2019 (version 2)

Copyright

© 2019, Rojec et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,772
    Page views
  • 712
    Downloads
  • 17
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Maria Rojec
  2. Antoine Hocher
  3. Kathryn M Stevens
  4. Matthias Merkenschlager
  5. Tobias Warnecke
(2019)
Chromatinization of Escherichia coli with archaeal histones
eLife 8:e49038.
https://doi.org/10.7554/eLife.49038

Further reading

    1. Chromosomes and Gene Expression
    2. Developmental Biology
    Virginia L Pimmett, Mounia Lagha
    Insight

    Imaging experiments reveal the complex and dynamic nature of the transcriptional hubs associated with Notch signaling.

    1. Chromosomes and Gene Expression
    2. Microbiology and Infectious Disease
    Abdoulie O Touray, Rishi Rajesh ... Igor Cestari
    Research Article

    African trypanosomes evade host immune clearance by antigenic variation, causing persistent infections in humans and animals. These parasites express a homogeneous surface coat of variant surface glycoproteins (VSGs). They transcribe one out of hundreds of VSG genes at a time from telomeric expression sites (ESs) and periodically change the VSG expressed by transcriptional switching or recombination. The mechanisms underlying the control of VSG switching and its developmental silencing remain elusive. We report that telomeric ES activation and silencing entail an on/off genetic switch controlled by a nuclear phosphoinositide signaling system. This system includes a nuclear phosphatidylinositol 5-phosphatase (PIP5Pase), its substrate PI(3,4,5)P3, and the repressor-activator protein 1 (RAP1). RAP1 binds to ES sequences flanking VSG genes via its DNA binding domains and represses VSG transcription. In contrast, PI(3,4,5)P3 binds to the N-terminus of RAP1 and controls its DNA binding activity. Transient inactivation of PIP5Pase results in the accumulation of nuclear PI(3,4,5)P3, which binds RAP1 and displaces it from ESs, activating transcription of silent ESs and VSG switching. The system is also required for the developmental silencing of VSG genes. The data provides a mechanism controlling reversible telomere silencing essential for the periodic switching in VSG expression and its developmental regulation.